WCG Clinical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of WCG Clinical generated cash of $124,201,000, which is more than the previous year. Cash used in financing activities reached the amount of $3,109,528,000 last year. Net change in cash is therefore $178,097,000.
Cash Flow
| 2019 | 61.39M | -101.86M | 38.74M |
|---|---|---|---|
| 2020 | 124.20M | -3.05B | 3.10B |
WCGC Cash Flow Statement (2019 – 2020)
| 2020 | 2019 | |
|---|---|---|
Cash at beginning of period | 0 | 35.12M |
Operating activities | ||
Net income | -95.27M | 18.19M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 205.69M | 64.60M |
Stock-based compensation expense | 4.59M | 1.00M |
| Deferred income tax benefit | 4.59M | 1.00M |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | -15.49M | -7.53M |
Inventories | 20.78M | 3.45M |
Accounts payable | 5.65M | -2.37M |
Cash generated by operating activities | 124.20M | 61.39M |
Investing activities | ||
Purchases Of Investments | 0 | 0 |
Investments In Property Plant And Equipment | -27.27M | -23.54M |
Acquisitions Net | -3.02B | -78.32M |
Cash generated by investing activities | -3.05B | -101.86M |
Financing activities | ||
Common Stock Issued | 0 | 0 |
Payments for dividends | 0 | 0 |
Repurchases of common stock | 0 | 0 |
Repayments of term debt | -129.97M | 49.08M |
Cash used in financing activities | 3.10B | 38.74M |
Net Change In Cash | 178.09M | -1.59M |
Cash at end of period | 178.09M | 33.53M |